Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Anatara Lifesciences Ltd leads the sector with a market cap of $1.40 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.06 Trillion
Companies Listed
1,295
Largest Company
Anatara Lifesciences Ltd
Top Biotechnology Stocks by Market Capitalization (October 2026)
Top Biotechnology stocks by market capitalization as of October 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1201 |
Anatara Lifesciences Ltd
AU:ANR |
$1.40 Million | AU$1.98 Million | Australia | AU$0.01 | +0.00% | -11.11% | 4.26 Million |
| 1202 |
Bioventix
LSE:BVXP |
$1.27 Million | GBX10.45 Billion | UK | GBX2000.00 | -1.23% | +0.00% | 434.60K |
| 1203 |
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX |
$1.27 Million | $1.27 Million | USA | $1.21 | -8.33% | -2.02% | 4.25 Million |
| 1204 |
Kezar Life Sciences Inc
NASDAQ:KZR |
$1.26 Million | $1.26 Million | USA | $0.17 | +6.25% | +17.24% | 20.41 Million |
| 1205 |
Biomx Inc
NYSE MKT:PHGE |
$1.25 Million | $1.25 Million | USA | $0.82 | +10.57% | +39.85% | 249.67 Million |
| 1206 |
Artelo Biosciences Inc
NASDAQ:ARTL |
$1.22 Million | $1.22 Million | USA | $2.22 | -3.90% | -12.94% | 1.07 Million |
| 1207 |
XTL Biopharmaceuticals Ltd
F:H2K2 |
$1.19 Million | €1.02 Million | Germany | €2.28 | +23.24% | +408.93% | 47.11K |
| 1208 |
2cureX AB
ST:2CUREX |
$1.13 Million | Skr10.54 Million | Sweden | Skr0.42 | -12.13% | -30.00% | 12.95 Million |
| 1209 |
Universal Ibogaine Inc
V:IBO |
$1.13 Million | CA$1.56 Million | Canada | CA$0.01 | +0.00% | +0.00% | 0.00 |
| 1210 |
Bone Biologics Corp
NASDAQ:BBLG |
$1.05 Million | $1.05 Million | USA | $0.38 | -2.03% | -6.31% | 881.61K |
| 1211 |
Moolec Science SA Ordinary Shares
NASDAQ:MLEC |
$1.02 Million | $1.02 Million | USA | $1.40 | +2.19% | -16.91% | 1.76 Million |
| 1212 |
PHAXIAM Therapeutics S.A.
PA:PHXM |
$1.01 Million | €863.96K | France | €0.10 | +0.00% | +0.00% | 0.00 |
| 1213 |
4BASEBIO UK SOCIETAS
LSE:4BB |
$998.55K | GBX8.21 Billion | UK | GBX530.00 | +0.00% | +0.95% | 17.84K |
| 1214 |
Biora Therapeutics Inc
NASDAQ:BIOR |
$994.99K | $994.99K | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 1215 |
Biora Therapeutics, Inc.
NASDAQ:BIORQ |
$994.99K | $994.99K | USA | $0.22 | +0.00% | +219900.00% | 34.53K |
| 1216 |
ExpreS2ion Biotech Holding AB
ST:EXPRS2 |
$993.40K | Skr9.23 Million | Sweden | Skr0.93 | +0.00% | -13.52% | 2.24 Million |
| 1217 |
Alligator Bioscience AB
ST:ATORX |
$985.08K | Skr9.15 Million | Sweden | Skr0.01 | -1.00% | -6.60% | 737.80 Million |
| 1218 |
BIOCURE TECHNOLOGY INC.
F:1WH |
$960.84K | €821.86K | Germany | €0.03 | +21.43% | +34.21% | 0.00 |
| 1219 |
2CUREX AB SEK-10
F:2QE |
$923.79K | €790.17K | Germany | €0.04 | -25.20% | -10.68% | 2.47K |
| 1220 |
PENTIXAPHARM HOLDING N AG
XETRA:PTP |
$922.50K | €789.07K | Germany | €1.69 | +0.90% | -4.25% | 252.61K |
| 1221 |
Geneuro SA
PA:GNRO |
$911.56K | €779.71K | France | €0.03 | +0.00% | +0.00% | 0.00 |
| 1222 |
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA |
$866.26K | $866.26K | USA | $0.11 | +8.08% | +7.86% | 112.45K |
| 1223 |
Ovoca Gold PLC
IR:OVXA |
$856.42K | €732.54K | Ireland | €0.01 | +0.00% | +0.00% | 0.00 |
| 1224 |
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN |
$807.35K | $807.35K | USA | $0.15 | +2.04% | -12.11% | 296.90 Million |
| 1225 |
Lunai Bioworks Inc.
NASDAQ:LNAI |
$747.19K | $747.19K | USA | $0.16 | -30.20% | -68.19% | 14.13 Million |
| 1226 |
Enveric Biosciences Inc
NASDAQ:ENVB |
$741.16K | $741.16K | USA | $1.43 | -2.05% | -2.05% | 1.31 Million |
| 1227 |
ALGERNON PHARMACEUT. A
F:AGW0 |
$740.91K | €633.74K | Germany | €0.02 | +0.00% | +0.00% | 508.00 |
| 1228 |
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO |
$716.31K | $716.31K | USA | $0.01 | +30.00% | -18.75% | 10.88 Million |
| 1229 |
Diagonal Bio AB
ST:DIABIO |
$703.53K | Skr6.54 Million | Sweden | Skr0.00 | +0.00% | +0.00% | 53.13 Million |
| 1230 |
Decoy Therapeutics Inc.
NASDAQ:DCOY |
$701.05K | $701.05K | USA | $1.07 | -13.01% | +3.88% | 2.81 Million |
| 1231 |
Ondine Biomedical Inc
LSE:OBI |
$665.77K | GBX5.47 Billion | UK | GBX9.75 | +0.00% | -4.88% | 14.10 Million |
| 1232 |
Onconetix Inc
NASDAQ:ONCO |
$643.16K | $643.16K | USA | $0.56 | -4.27% | +37.84% | 115.70 Million |
| 1233 |
IO Biotech Inc
NASDAQ:IOBT |
$611.57K | $611.57K | USA | $0.01 | +3.66% | +150.00% | 11.67 Million |
| 1234 |
Poolbeg Pharma PLC
LSE:POLB |
$603.77K | GBX4.96 Billion | UK | GBX6.50 | +0.00% | +0.00% | 24.00 Million |
| 1235 |
Integragen
PA:ALINT |
$579.30K | €495.51K | France | €0.08 | +15.38% | +7.14% | 3.07 Million |
| 1236 |
PROMIS NEUROSCIENCES
F:23J0 |
$576.86K | €493.42K | Germany | €6.90 | +2.99% | +1849.15% | 110.14K |
| 1237 |
Aptorum Group Ltd Class A
NASDAQ:APM |
$570.06K | $570.06K | USA | $8.32 | -2.92% | +1101.62% | 4.93 Million |
| 1238 |
BRAXIA SCIENTIFIC CORP.
F:4960 |
$566.56K | €484.61K | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1239 |
Magle Chemoswed Holding Ab
ST:MAGLE |
$564.44K | Skr5.24 Million | Sweden | Skr0.25 | +7.63% | -6.62% | 7.57 Million |
| 1240 |
Valion Bio Inc
NASDAQ:VBIO |
$488.17K | $488.17K | USA | $0.55 | -10.83% | -42.47% | 87.73 Million |
| 1241 |
Appili Therapeutics Inc
TO:APLI |
$464.29K | CA$641.83K | Canada | CA$0.01 | -50.00% | -66.67% | 2.51 Million |
| 1242 |
CELLECTAR NEW22 DL-00001
F:NV4 |
$451.63K | €386.30K | Germany | €0.25 | +0.00% | +0.00% | 0.00 |
| 1243 |
Faron Pharmaceuticals Oy
LSE:FARN |
$436.55K | GBX3.59 Billion | UK | GBX31.50 | +0.00% | -5.97% | 825.53K |
| 1244 |
Waverley Pharma Inc
V:WAVE |
$390.63K | CA$540.00K | Canada | CA$0.01 | +0.00% | -33.33% | 247.19K |
| 1245 |
Arecor Therapeutics PLC
LSE:AREC |
$379.00K | GBX3.11 Billion | UK | GBX82.50 | +0.00% | +0.00% | 735.62K |
| 1246 |
GeoVax Labs Inc
NASDAQ:GOVX |
$374.90K | $374.90K | USA | $0.17 | -9.31% | -20.73% | 18.87 Million |
| 1247 |
ALBERT LABS INTL. CORP.
F:VB50 |
$372.07K | €318.25K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1248 |
Hemogenyx Pharmaceuticals PLC
LSE:HEMO |
$369.21K | GBX3.03 Billion | UK | GBX566.00 | -16.76% | -21.93% | 607.77K |
| 1249 |
Lidds AB
ST:LIDDS |
$361.27K | Skr3.36 Million | Sweden | Skr0.02 | +0.00% | +17.14% | 8.44 Million |
| 1250 |
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ:LABT |
$350.13K | $350.13K | USA | $0.20 | -15.72% | -59.18% | 86.51 Million |
| 1251 |
Lyra Therapeutics Inc
NASDAQ:LYRA |
$337.23K | $337.23K | USA | $0.20 | +0.00% | +0.00% | 26.03K |
| 1252 |
Qlucore AB (publ)
ST:NOVKAN |
$326.04K | Skr3.03 Million | USA | Skr0.03 | -43.95% | -54.46% | 38.54 Million |
| 1253 |
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI |
$319.55K | $319.55K | USA | $0.47 | -9.05% | -22.82% | 68.14 Million |
| 1254 |
IXICO PLC
LSE:IXI |
$313.05K | GBX2.57 Billion | UK | GBX11.75 | +0.00% | +20.51% | 4.53 Million |
| 1255 |
SkinBioTherapeutics PLC
LSE:SBTX |
$307.45K | GBX2.53 Billion | UK | GBX9.75 | +0.00% | +24.20% | 55.90 Million |
| 1256 |
PCI Biotech Holding ASA
OL:PCIB |
$274.95K | Nkr2.61 Million | Norway | Nkr0.07 | -39.13% | -53.95% | 22.88 Million |
| 1257 |
Virpax Pharmaceuticals Inc
NASDAQ:VRPX |
$273.35K | $273.35K | USA | $0.22 | +0.00% | +0.00% | 157.00 |
| 1258 |
Sareum Hldgs Plc
LSE:SAR |
$257.11K | GBX2.11 Billion | UK | GBX15.25 | +0.00% | -44.55% | 11.08 Million |
| 1259 |
Kiromic Biopharma Inc
NASDAQ:KRBP |
$214.93K | $214.93K | USA | $22.96 | +1.39% | +1.39% | 35.00 |
| 1260 |
ImmuPharma PLC
LSE:IMM |
$198.79K | GBX1.63 Billion | UK | GBX3.25 | -16.67% | -12.16% | 65.41 Million |
| 1261 |
Vaxil Bio Ltd
V:VXL |
$198.18K | CA$273.96K | Canada | CA$0.10 | -23.08% | -31.03% | 109.34K |
| 1262 |
Roquefort Investments PLC
LSE:ROQ |
$184.27K | GBX1.51 Billion | UK | GBX9.25 | +873.68% | +802.44% | 23.80 Million |
| 1263 |
HAVN LIFE SCIENCES INC.
F:5NP0 |
$172.31K | €147.39K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1264 |
QuiaPEG Pharmaceuticals Holding AB
ST:QUIA |
$141.00K | Skr1.31 Million | Sweden | Skr0.00 | -16.67% | -44.44% | 1.38 Billion |
| 1265 |
Enlivex Therapeutics Ltd
TA:ENLV |
$126.77K | ILA47.29 Million | Israel | ILA0.20 | -21.57% | -85.24% | 8.81 Million |
| 1266 |
Biosergen AS
ST:BIOSGN |
$124.84K | Skr1.16 Million | Sweden | Skr0.49 | -0.40% | +0.00% | 8.49 Million |
| 1267 |
Chimeric Therapeutics Ltd
AU:CHM |
$110.00K | AU$155.47K | Australia | AU$0.00 | +0.00% | +0.00% | 27.32 Million |
| 1268 |
Scandion Oncology A/S
ST:SCOL |
$103.58K | Skr962.52K | Sweden | Skr0.00 | +0.00% | +0.00% | 29.31 Million |
| 1269 |
Lipigon Pharmaceuticals AB
ST:LPGO |
$97.81K | Skr908.90K | Sweden | Skr0.00 | -44.44% | -61.54% | 559.62 Million |
| 1270 |
Aptamer Group PLC
LSE:APTA |
$96.80K | GBX795.61 Million | UK | GBX0.30 | +0.00% | -6.35% | 112.22 Million |
| 1271 |
NANOSPHERE HEA.SCIENCES
F:2CG |
$96.10K | €82.20K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1272 |
CRISM Therapeutics Corporation
LSE:CRTX |
$84.30K | GBX692.87 Million | UK | GBX8.75 | +0.00% | +0.00% | 1.35 Million |
| 1273 |
Fusion Antibodies PLC
LSE:FAB |
$82.97K | GBX681.94 Million | UK | GBX6.00 | -5.51% | +4.35% | 17.26 Million |
| 1274 |
Oxurion NV
BR:OXUR |
$82.95K | €70.95K | Belgium | €0.00 | +33.33% | +0.00% | 89.70 Million |
| 1275 |
OptiBiotix Health Plc
LSE:OPTI |
$72.90K | GBX599.14 Million | UK | GBX5.80 | +0.00% | +2.65% | 1.40 Million |
| 1276 |
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC |
$68.05K | $68.05K | USA | $0.02 | +0.00% | +18.11% | 139.03K |
| 1277 |
Cizzle Biotechnology Holdings PLC
LSE:CIZ |
$53.05K | GBX436.03 Million | UK | GBX1.10 | -4.35% | +7.32% | 34.18 Million |
| 1278 |
Nuformix plc
LSE:NFX |
$33.34K | GBX274.02 Million | UK | GBX0.11 | +0.00% | +5.00% | 414.91 Million |
| 1279 |
Carisma Therapeutics Inc.
NASDAQ:CARM |
$29.29K | $29.29K | USA | $0.00 | +0.00% | -38.46% | 222.73K |
| 1280 |
Physiomics Plc
LSE:PYC |
$23.44K | GBX192.61 Million | UK | GBX0.43 | +0.00% | -10.53% | 50.10 Million |
| 1281 |
BSF Enterprise Plc
LSE:BSFA |
$14.06K | GBX115.54 Million | UK | GBX0.90 | +0.00% | -5.26% | 44.71 Million |
| 1282 |
Futura Medical
LSE:FUM |
$12.38K | GBX101.73 Million | UK | GBX0.18 | -7.41% | -2.78% | 341.48 Million |
| 1283 |
Windtree Therapeutics Inc
NASDAQ:WINT |
$6.74K | $6.74K | USA | $0.00 | -33.33% | +0.00% | 902.35K |
| 1284 |
CannBioRx Life Sciences Corp
NASDAQ:ATNFW |
$4.09K | $4.09K | USA | $0.43 | +0.00% | +0.00% | 1.65 Million |
| 1285 |
Conduit Pharmaceuticals Inc.
NASDAQ:CDT |
$2.76K | $2.76K | USA | $0.07 | -11.69% | -47.69% | 235.16 Million |
| 1286 |
Lipella Pharmaceuticals Inc. Common Stock
NASDAQ:LIPO |
$2.31K | $2.31K | USA | $0.00 | +0.00% | +150.00% | 316.43K |
| 1287 |
Effector Therapeutics Inc
NASDAQ:EFTR |
$940.00 | $940.00 | USA | $0.00 | +0.00% | +0.00% | 132.13K |
| 1288 |
Tissue Regenix Group Plc
LSE:TRX |
$628.37 | GBX5.16 Million | UK | GBX0.07 | +0.00% | +0.00% | 0.00 |
| 1289 |
Trevena Inc
NASDAQ:TRVN |
$345.52 | $345.52 | USA | $0.00 | -60.00% | -60.00% | 3.32K |
| 1290 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXTW |
$219.89 | $219.89 | USA | $0.02 | -0.45% | -68.35% | 970.70K |
| 1291 |
NLS Pharmaceutics AG
NASDAQ:NLSPW |
$161.60 | $161.60 | USA | $0.02 | +0.00% | +0.00% | 14.34K |
| 1292 |
Seelos Therapeutics, Inc.
NASDAQ:SEELQ |
$58.00 | $58.00 | USA | $0.00 | +0.00% | +0.00% | 0.00 |
| 1293 |
Reviva Pharmaceuticals Holdings Inc
NASDAQ:RVPHW |
$29.32 | $29.32 | USA | $0.00 | -16.67% | -69.07% | 3.22 Million |
| 1294 |
immatics biotechnologies GmbH
NASDAQ:IMTXW |
$5.77 | $5.77 | USA | $0.00 | +0.00% | +0.00% | 39.12K |
| 1295 |
Neovacs S.A.
PA:ALNEV |
$5.24 | €4.48 | France | €0.10 | -1.24% | -4.70% | 1.47 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries